Entrée Capital Bio

OTHER INVESTMENTS
Written By Federico de Mateo

Entrée Bio is an early-stage VC fund investing at the intersection of biotechnology, bioconvergence, and deep tech. Based in Israel and

Boston, it leverages Entrée Capital’s unique status and know-how as a global leader in technology and innovation to identify and support scalable solutions

that improve human lives, health span, longevity and assuring best-in-class preventive care.

Visit Entree Capital Website
Federico de Mateo
Previous

KIWI Crédito
Next

ONESTEP